High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study

CONCLUSIONS: Adding a higher dose of rhTPO can further accelerate platelet recovery and platelet transfusion independence in patients with newly diagnosed NSAA.PMID:38156735 | DOI:10.1080/16078454.2023.2298523

Source: Hematology - December 29, 2023 Category: Hematology Authors: Yuan Yang Qinglin Hu Chen Yang Miao Chen Bing Han Source Type: research